6ut0: Difference between revisions
Jump to navigation
Jump to search
m Protected "6ut0" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
==Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer== | |||
<StructureSection load='6ut0' size='340' side='right'caption='[[6ut0]]' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UT0 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6UT0 FirstGlance]. <br> | |||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6ut0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ut0 OCA], [http://pdbe.org/6ut0 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ut0 RCSB], [http://www.ebi.ac.uk/pdbsum/6ut0 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ut0 ProSAT]</span></td></tr> | |||
[[Category: | </table> | ||
[[Category: Smith | __TOC__ | ||
[[Category: Vigers | </StructureSection> | ||
[[Category: Large Structures]] | |||
[[Category: Smith DJ]] | |||
[[Category: Vigers GP]] |
Revision as of 08:46, 22 April 2020
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of CancerIdentification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
Structural highlights
|
|